Laura Hamill Jazz Pharmaceuticals PLC (JAZZ) insider trading activity

JAZZ Quotes by TradingView

Laura Hamill is Director of Jazz Pharmaceuticals plc. Currently has a direct ownership of 6,933 shares of JAZZ, which is worth approximately $767,829. The most recent transaction as insider was on Aug 08, 2025, when has been sold 1,805 shares (Ordinary Shares) at a price of $111.25 per share, resulting in proceeds of $200,806. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.93K
32.54% 3M change
32.54% 12M change
Total Value Held $767,829

Laura Hamill Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 08 2025
SELL
Payment of exercise price or tax liability
$200,806 $111.25 p/Share
1,805 Reduced 20.66%
6,933 Ordinary Shares
Aug 07 2025
BUY
Grant, award, or other acquisition
-
3,507 Added 28.64%
8,738 Ordinary Shares
Aug 02 2024
BUY
Grant, award, or other acquisition
-
3,731 Added 41.63%
5,231 Ordinary Shares

Also insider at

XLRN
ACCELERON PHARMA INC Healthcare
Director
ANAB
ANAPTYSBIO, INC Healthcare
Director
YMAB
Y-mAbs Therapeutics, Inc. Healthcare
PRDS
PARDES BIOSCIENCES, INC. Healthcare
Director
VCKA
Vickers Vantage Corp. I Financial Services
Director
LH

Laura Hamill

Director
New York, NY

Track Institutional and Insider Activities on JAZZ

Follow Jazz Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

News

Receive news related to Jazz Pharmaceuticals plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JAZZ